Patent details
EP2155195
Title:
Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
Basic Information
- Publication number:
- EP2155195
- PCT Application Number:
- PCT/US/2008/004760
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087428207
- PCT Publication Number:
- WO/2008/127682
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
- French Title of Invention:
- Combinaison d'une thérapie anticoagulante à un composé agissant en tant qu'inhibiteur de facteur Xa
- German Title of Invention:
- Gerinnungshemmende Kombinationstherapie mit einer Verbindung, die als Faktor-Xa-Hemmer wirkt
- SPC Number:
-
Dates
- Filing date:
- 11/04/2008
- Grant date:
- 16/07/2014
- EP Publication Date:
- 16/07/2014
- PCT Publication Date:
- 23/10/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/02/2010
- EP B1 Publication Date:
- 16/07/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/04/2015
- Expiration date:
- 11/04/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/04/2008
-
-
- Name:
- Millennium Pharmaceuticals Inc.
- Address:
- 40 Landsdowne Street, Cambridge, MA 02139, United States (US)
Inventor
1
- Name:
- SINHA Uma
- Address:
- United States (US)
2
- Name:
- HOLLENBACH Stanley, J.
- Address:
- United States (US)
3
- Name:
- ANDRE Patrick
- Address:
- United States (US)
Priority
- Priority Number:
- 911852 P
- Priority Date:
- 13/04/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/4365;
Filing date |
Document type |
Number of pages |